KPV (30 Capsules)

KPV (Lysine-Proline-Valine) is a naturally occurring tripeptide derived from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH), a peptide known for its anti-inflammatory and immunomodulatory effects. KPV retains the key biological activity of α-MSH without engaging melanocortin receptors responsible for pigmentation, making it a targeted and non-pigmenting anti-inflammatory agent in preclinical research.

It has been studied in models of inflammatory bowel disease (IBD), autoimmune dysfunction, wound healing, and dermatological inflammation, with promising results in reducing pro-inflammatory cytokines such as TNF-α, IL-6, and IFN-γ.

How KPV Works (Based on Preclinical Research):

• Reduces inflammation by downregulating key pro-inflammatory cytokines

• Bypasses melanogenic activity for targeted, non-hormonal immune support

• Modulates immune cell signaling and epithelial repair pathways

• Suitable for topical, oral, or injectable research models

Potential Benefits (Based on Preclinical Research):

• May support treatment of colitis and intestinal barrier integrity

• Accelerated healing of skin, soft tissue, and mucosal linings

• Reduced local and systemic inflammatory responses

• No pigmentation or hormonal disruption observed in studies

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.